ImageVerifierCode 换一换
格式:PPT , 页数:17 ,大小:928KB ,
资源ID:3364473      下载积分:20 金币
快捷下载
登录下载
邮箱/手机:
温馨提示:
快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。 如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝    微信支付   
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【https://www.docduoduo.com/d-3364473.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录   QQ登录   微博登录 

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(药理学总论-绪言【-ppt】.ppt)为本站会员(微传9988)主动上传,道客多多仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知道客多多(发送邮件至docduoduo@163.com或直接QQ联系客服),我们立即给予删除!

药理学总论-绪言【-ppt】.ppt

1、药理学总论-绪言 Pharmacology A Very Basic Intro,What is a drug?any chemical agent whichaffects any biological process,Sources of Drugs,Animals Plants Minerals Synthetic Microbes Genetic engineering drugs,基因工程药物过程示意图,从细胞中分离出DNA,限制酶截取DNA片断,分离大肠杆菌中的质粒, DNA重组,用重组质粒转化大肠杆菌,培养大肠杆菌克隆大量基因,A goal of Genomics is to f

2、ind and express genes that code for unknown peptides with significant biological properties, like receptors or enzymes. In a reverse Pharmacology approach this peptide, e.g. a receptor, is then used to “fish“ for a natural ligand . With receptor and ligand in hand the biological role of the receptor

3、 needs to be determined. Finally, screening for synthetic ligands as well as lead optimization can lead to new drug candidates. In contrast, the classical approach to drug discovery starts with the identification of a ligand that has biological activity that in turn is used to “fish“ for the corresp

4、onding receptor.,One example for a Genomics strategy aims at identifying drug targets based on molecular homology within Gene-families. One of the most important families of drug-targets for the pharmaceutical industry is the family of G-protein coupled receptors (GPCRs). Of the top 200 best selling

5、 prescription drugs, more than 20% interact with GPCRs, providing worldwide sales of over $20 billion. The characteristic motif of the GPCR family is the seven distinct hydrophobic regions, each of 20 to 30 amino acids that form the transmembrane domain of these integral membrane proteins. This key

6、amino-acid sequence motif can be found within all types of GPCRs and can be used to identify DNA-sequences that code for GPCRs.,What is pharmacology ?the study of how drugs effect biological systems,What is Pharmacology ?,Pharmacology,Pharmacokinetics PharmacodynamicsWhat the body does to drug What

7、the drug does to body,Pharmacotherapeutics PharmacocognosyThe study of the use of drugs Identifying crude materials as drugs,Toxicology,Pharmacokinetics What the body does to the drug- Absorption - Distribution - Metabolism (Biotransformation) - Excretion,Half-life (t1/2) - the time required for the

8、 plasma concentration of a drug to be reduced by 50 %,DRUG CLASSIFICATION Based on the chemical structure - Based on the main effect (e.g. analgesics). - Based on the therapeutic use (e.g. antipsychotic 安定药). Based on mechanism of action (e.g. serotonin agonist).,From Chemist to First In Man approxi

9、mately 7 10 yearsHow a Drug becomes a drug,H. Haarmann University of Maryland, 2002,Basic & Clinical Evaluation of New DrugsDrug discovery & Drug screeningChemistryIn Vitro StudiesFunction in cells, tissues, and at receptors2. Preclinical safety & toxicity testingIn Vivo - Animal studiesPharmacology

10、 and Behavioral PharmacologyPotency and Efficacy ED50Tolerance and Tachyphylaxis(快速耐受) Toxicity Acute and Chronic LD50Teratogenicity = birth defectsCarcinogenicity = cancerous3. Evaluation of drug in humans,Evaluating Drugs in Humans,The Food and Drug Administration (FDA),Phases of a Clinical Trials

11、 Phase I Phase II Phase III Phase IV,Evaluating Drugs in Humans,Phase I Healthy adult volunteersEvaluation of safety, Pharmacokinetics (PK), side effects?Phase II - PatientsEvaluation of efficacy, safety, PK, and side effectsDouble-blind placebo controlledPhase III Specific patient subpopulationsDet

12、ermine efficacy for specific indicationsLarge sample of specific patients (1,000)Randomized double-blind placebo controlledPhase IV Post FDA ApprovalDetermine efficacy for specific indicationDetermine drug utilization patterns and additional efficacyMonitor rare, severe side effects/toxicity,Drug No

13、menclature,Chemical name(化学名)- *Generic name (非专利名) Trade name (商品名),Chemical Name: 2-(4-isobutylphenyl)-propionic acidGeneric Name: ibuprofen(布洛芬)Trade Names: Advil, Aches-N-Pain, Brufen, Emodin, Haltran, Medipren,Midol 200, Motrin, Nuprin,Rufen, Trendar, Wal-Profen,*preclinical nomenclature = company abbrev-123456 (e.g. WAY-100635, MK-869),

本站链接:文库   一言   我酷   合作


客服QQ:2549714901微博号:道客多多官方知乎号:道客多多

经营许可证编号: 粤ICP备2021046453号世界地图

道客多多©版权所有2020-2025营业执照举报